Literature DB >> 21477106

Association of genetic variation in cannabinoid mechanisms and gastric motor functions and satiation in overweight and obesity.

M I Vazquez-Roque1, M Camilleri, A Vella, P Carlson, J Laugen, A R Zinsmeister.   

Abstract

BACKGROUND: The endocannabinoid system is associated with food intake. We hypothesized that genes regulating cannabinoids are associated with obesity. Genetic variations in fatty acid amide hydroxylase (FAAH) and cannabinoid receptor 1 (CNR1) are associated with satiation and gastric motor function.
METHODS: In 62 overweight or obese adults of European ancestry, single nucleotide polymorphisms of rs806378 (nearest gene CNR1) and rs324420 (nearest gene FAAH) were genotyped and the associations with gastric emptying (GE) of solids and liquids, gastric volume (GV), and satiation [maximum tolerated volume (MTV) and symptoms after Ensure(®) nutrient drink test] were explored using a dominant genetic model, with gender and BMI as covariates. KEY
RESULTS: rs806378 CC genotype was associated with reduced fasting GV (210.2±11.0mL for CC group compared to 242.5±11.3mL for CT/TT group, P=0.031) and a modest, non-significant association with GE of solids (P=0.17). rs324420 genotype was not associated with alterations in gastric motor functions; however, there was a difference in the Ensure(®) MTV (1174.6±37.2mL for CC group compared to 1395.0±123.1mL for CA/AA group, P=0.046) suggesting higher satiation with CC genotype. CONCLUSIONS & INFERENCES: Our data suggest that CNR1 and FAAH are associated with altered gastric functions or satiation that may predispose to obesity.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21477106      PMCID: PMC3117918          DOI: 10.1111/j.1365-2982.2011.01711.x

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  39 in total

1.  SPECT imaging of the stomach: comparison with barostat, and effects of sex, age, body mass index, and fundoplication. Single photon emission computed tomography.

Authors:  E P Bouras; S Delgado-Aros; M Camilleri; E J Castillo; D D Burton; G M Thomforde; H J Chial
Journal:  Gut       Date:  2002-12       Impact factor: 23.059

2.  Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study.

Authors:  Luc F Van Gaal; Aila M Rissanen; André J Scheen; Olivier Ziegler; Stephan Rössner
Journal:  Lancet       Date:  2005 Apr 16-22       Impact factor: 79.321

3.  The role of the stomach in eating.

Authors:  J A Deutsch
Journal:  Am J Clin Nutr       Date:  1985-11       Impact factor: 7.045

4.  The stomach signals satiety.

Authors:  J A Deutsch; W G Young; T J Kalogeris
Journal:  Science       Date:  1978-07-14       Impact factor: 47.728

5.  Overweight and obesity associated with a missense polymorphism in fatty acid amide hydrolase (FAAH).

Authors:  J C Sipe; J Waalen; A Gerber; E Beutler
Journal:  Int J Obes (Lond)       Date:  2005-07       Impact factor: 5.095

6.  Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity.

Authors:  Douglas Osei-Hyiaman; Michael DePetrillo; Pál Pacher; Jie Liu; Svetlana Radaeva; Sándor Bátkai; Judith Harvey-White; Ken Mackie; László Offertáler; Lei Wang; George Kunos
Journal:  J Clin Invest       Date:  2005-05       Impact factor: 14.808

7.  Comparison of gastric volumes in response to isocaloric liquid and mixed meals in humans.

Authors:  H De Schepper; M Camilleri; F Cremonini; A Foxx-Orenstein; D Burton
Journal:  Neurogastroenterol Motil       Date:  2004-10       Impact factor: 3.598

8.  Reduced cellular expression and activity of the P129T mutant of human fatty acid amide hydrolase: evidence for a link between defects in the endocannabinoid system and problem drug use.

Authors:  Kyle P Chiang; Alexandra L Gerber; Jack C Sipe; Benjamin F Cravatt
Journal:  Hum Mol Genet       Date:  2004-07-14       Impact factor: 6.150

9.  Independent influences of body mass and gastric volumes on satiation in humans.

Authors:  Silvia Delgado-Aros; Filippo Cremonini; Janet E Castillo; Heather J Chial; Duane D Burton; Irene Ferber; Michael Camilleri
Journal:  Gastroenterology       Date:  2004-02       Impact factor: 22.682

10.  Expression of cannabinoid CB1 receptors by vagal afferent neurons is inhibited by cholecystokinin.

Authors:  Galina Burdyga; Simon Lal; Andrea Varro; Rod Dimaline; David G Thompson; Graham J Dockray
Journal:  J Neurosci       Date:  2004-03-17       Impact factor: 6.167

View more
  8 in total

1.  Randomized pharmacodynamic and pharmacogenetic trial of dronabinol effects on colon transit in irritable bowel syndrome-diarrhea.

Authors:  B S Wong; M Camilleri; D Eckert; P Carlson; M Ryks; D Burton; A R Zinsmeister
Journal:  Neurogastroenterol Motil       Date:  2012-01-30       Impact factor: 3.598

2.  Association of melanocortin 4 receptor gene variation with satiation and gastric emptying in overweight and obese adults.

Authors:  Andres Acosta; Michael Camilleri; Andrea Shin; Paula Carlson; Duane Burton; Jessica O'Neill; Deborah Eckert; Alan R Zinsmeister
Journal:  Genes Nutr       Date:  2014-01-24       Impact factor: 5.523

Review 3.  Gastrointestinal morbidity in obesity.

Authors:  Andres Acosta; Michael Camilleri
Journal:  Ann N Y Acad Sci       Date:  2014-03-06       Impact factor: 5.691

4.  Quantitative gastrointestinal and psychological traits associated with obesity and response to weight-loss therapy.

Authors:  Andres Acosta; Michael Camilleri; Andrea Shin; Maria I Vazquez-Roque; Johanna Iturrino; Duane Burton; Jessica O'Neill; Deborah Eckert; Alan R Zinsmeister
Journal:  Gastroenterology       Date:  2014-12-06       Impact factor: 22.682

5.  Cannabinoid receptor 1 gene and irritable bowel syndrome: phenotype and quantitative traits.

Authors:  Michael Camilleri; Gururaj J Kolar; Maria I Vazquez-Roque; Paula Carlson; Duane D Burton; Alan R Zinsmeister
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-01-10       Impact factor: 4.052

6.  Role for fatty acid amide hydrolase (FAAH) in the leptin-mediated effects on feeding and energy balance.

Authors:  Georgia Balsevich; Martin Sticht; Nicole P Bowles; Arashdeep Singh; Tiffany T Y Lee; Zhiying Li; Prasanth K Chelikani; Francis S Lee; Stephanie L Borgland; Cecilia J Hillard; Bruce S McEwen; Matthew N Hill
Journal:  Proc Natl Acad Sci U S A       Date:  2018-07-02       Impact factor: 11.205

Review 7.  What Role Does the Endocannabinoid System Play in the Pathogenesis of Obesity?

Authors:  Piotr Schulz; Szymon Hryhorowicz; Anna Maria Rychter; Agnieszka Zawada; Ryszard Słomski; Agnieszka Dobrowolska; Iwona Krela-Kaźmierczak
Journal:  Nutrients       Date:  2021-01-26       Impact factor: 5.717

Review 8.  Potential of Fatty Acid Amide Hydrolase (FAAH), Monoacylglycerol Lipase (MAGL), and Diacylglycerol Lipase (DAGL) Enzymes as Targets for Obesity Treatment: A Narrative Review.

Authors:  Justin Matheson; Xin Ming Matthew Zhou; Zoe Bourgault; Bernard Le Foll
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.